← Leaderboards
Valentina Fokina Bryant
University Of Texas Med Br Galveston
$1,218,420
Attributed
$1,218,420
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.8K · FY2022–24$500K$375K$250K$125K$0
'22
'23
'24
Funding mix
By agency
NIH$1,218,420 · 1
By mechanism
R01$1,218,420 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Maged Costantine$5,049,405
- Madhu Lata S. Chauhan$1,175,978
- Kirsten Lawrence Cleary$70,896
- Shannon Michelle Clark$0
Others in their field
Other Rising Stars on “Japan”
- Galina Vid · Ceramedix Holding, Llc$3,007,043
- David S Bergsman · University Of Washington$3,000,000
- Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston$2,100,123
- Giulietta Maria Riboldi · New York University School Of Medicine$2,066,422
- Fernando J Benavides · University Of Tx Md Anderson Can Ctr$1,863,592
- Ethan Perlstein · Maggie'S Pearl, Llc$1,805,996
Research focus
JapanMortalityHelicaseIn VitroExposure ToMorbidity - Disease RateFetusHazardHerpes Zoster DiseaseInvestigationDrug DistributionAnimal ModelExperimental ModelsMembrane Transport ProteinsFetalFetal SafetyAlternative TreatmentGenital HerpesDna PrimaseClinical DevelopmentInhibitorDevelopmental ToxicityAcyclovirMothers
Grant awards (4)
Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models$356,386
R01 · FY2024 · HD · contact PI
Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models$24,526
R01 · FY2024 · HD · contact PI
Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models$418,754
R01 · FY2023 · HD · contact PI
Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models$418,754
R01 · FY2022 · HD · contact PI